Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.61 | 0.03 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |